CA2108041A1
(en)
*
|
1991-03-29 |
1992-09-30 |
Nicholas S. Bodor |
Targeted drug delivery via mixed phosphate derivatives
|
DE4142570A1
(de)
*
|
1991-12-21 |
1993-06-24 |
Basf Ag |
Glykolaldehyd- und milchsaeurederivate, deren herstellung und verwendung
|
GB9205917D0
(en)
*
|
1992-03-18 |
1992-04-29 |
Smithkline Beecham Plc |
Pharmaceuticals
|
FR2691463A1
(fr)
*
|
1992-05-25 |
1993-11-26 |
Centre Nat Rech Scient |
Dérivés nucléotidiques, leur préparation et leur application en thérapeutique.
|
US5770725A
(en)
*
|
1992-05-25 |
1998-06-23 |
Gosselin; Gilles |
Phosphotriester type biologically active compounds
|
FR2692265B1
(fr)
|
1992-05-25 |
1996-11-08 |
Centre Nat Rech Scient |
Composes biologiquement actifs de type phosphotriesters.
|
US6020482A
(en)
*
|
1992-05-25 |
2000-02-01 |
Gosselin; Gilles |
Phosphotriester type biologically active compounds
|
US5849905A
(en)
*
|
1994-11-23 |
1998-12-15 |
Centre National De La Recherche Scientifique |
Biologically active phosphotriester-type nucleosides and methods for preparing same
|
US6057305A
(en)
*
|
1992-08-05 |
2000-05-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Antiretroviral enantiomeric nucleotide analogs
|
US5817647A
(en)
*
|
1993-04-01 |
1998-10-06 |
Merrell Pharmaceuticals Inc. |
Unsaturated acetylene phosphonate derivatives of purines
|
US5955591A
(en)
*
|
1993-05-12 |
1999-09-21 |
Imbach; Jean-Louis |
Phosphotriester oligonucleotides, amidites and method of preparation
|
ATE199906T1
(de)
*
|
1993-06-29 |
2001-04-15 |
Mitsubishi Chem Corp |
Phosphonat-nukleotid ester-derivate
|
AU690587B2
(en)
*
|
1993-09-17 |
1998-04-30 |
Gilead Sciences, Inc. |
Method for dosing therapeutic compounds
|
US5656745A
(en)
*
|
1993-09-17 |
1997-08-12 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
EP0719273B1
(en)
*
|
1993-09-17 |
2010-11-03 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
US5798340A
(en)
|
1993-09-17 |
1998-08-25 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
US5627185A
(en)
*
|
1994-11-23 |
1997-05-06 |
Gosselin; Gilles |
Acyclovir derivatives as antiviral agents
|
US5977061A
(en)
*
|
1995-04-21 |
1999-11-02 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
N6 - substituted nucleotide analagues and their use
|
US5717095A
(en)
*
|
1995-12-29 |
1998-02-10 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
CA2239020A1
(en)
*
|
1995-12-29 |
1997-07-10 |
Norbert W. Bischofberger |
Nucleotide analogs
|
US6093816A
(en)
|
1996-06-27 |
2000-07-25 |
Isis Pharmaceuticals, Inc. |
Cationic lipids
|
CA2261619C
(en)
*
|
1996-07-26 |
2006-05-23 |
Gilead Sciences, Inc. |
Nucleotide analogs
|
NZ333687A
(en)
*
|
1996-07-26 |
2000-08-25 |
Gilead Sciences Inc |
Phosphonomethoxy nucleotide analogs
|
US5922695A
(en)
*
|
1996-07-26 |
1999-07-13 |
Gilead Sciences, Inc. |
Antiviral phosphonomethyoxy nucleotide analogs having increased oral bioavarilability
|
ZA986614B
(en)
|
1997-07-25 |
1999-01-27 |
Gilead Sciences |
Nucleotide analog composition
|
CN1763057B
(zh)
*
|
1997-07-25 |
2012-10-17 |
吉尔利德科学股份有限公司 |
核苷酸类似物组合物
|
US5935946A
(en)
*
|
1997-07-25 |
1999-08-10 |
Gilead Sciences, Inc. |
Nucleotide analog composition and synthesis method
|
CA2596320C
(en)
*
|
1997-07-25 |
2008-12-23 |
Gilead Sciences, Inc. |
Nucleotide analog compositions
|
US6312662B1
(en)
|
1998-03-06 |
2001-11-06 |
Metabasis Therapeutics, Inc. |
Prodrugs phosphorus-containing compounds
|
WO1999045016A2
(en)
|
1998-03-06 |
1999-09-10 |
Metabasis Therapeutics, Inc. |
Novel prodrugs for phosphorus-containing compounds
|
US6444652B1
(en)
|
1998-08-10 |
2002-09-03 |
Novirio Pharmaceuticals Limited |
β-L-2'-deoxy-nucleosides for the treatment of hepatitis B
|
AU5475799A
(en)
*
|
1998-08-10 |
2000-03-06 |
Centre National De La Recherche Scientifique |
Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis
|
TWI230618B
(en)
*
|
1998-12-15 |
2005-04-11 |
Gilead Sciences Inc |
Pharmaceutical compositions of 9-[2-[[bis[(pivaloyloxy)methyl]phosphono]methoxy]ethyl]adenine and tablets or capsules containing the same
|
US6635278B1
(en)
|
1998-12-15 |
2003-10-21 |
Gilead Sciences, Inc. |
Pharmaceutical formulations
|
EP1165570B9
(en)
*
|
1999-03-05 |
2007-02-21 |
Metabasis Therapeutics, Inc. |
Novel phosphorus-containing prodrugs
|
US7205404B1
(en)
|
1999-03-05 |
2007-04-17 |
Metabasis Therapeutics, Inc. |
Phosphorus-containing prodrugs
|
EP1210354A1
(en)
*
|
1999-09-08 |
2002-06-05 |
Metabasis Therapeutics, Inc. |
Prodrugs for liver specific drug delivery
|
US6716825B2
(en)
*
|
1999-12-03 |
2004-04-06 |
The Regents Of The University Of California |
Phosphonate compounds
|
JP2003531111A
(ja)
*
|
1999-12-17 |
2003-10-21 |
アライアッド・ファーマシューティカルズ・インコーポレーテッド |
プロトンポンプインヒビター
|
US20020056123A1
(en)
*
|
2000-03-09 |
2002-05-09 |
Gad Liwerant |
Sharing a streaming video
|
ES2536972T5
(es)
|
2000-07-21 |
2022-04-06 |
Gilead Sciences Inc |
Profármacos de análogos de nucleótidos de fosfonato y métodos para seleccionar y preparar los mismos
|
MY141789A
(en)
*
|
2001-01-19 |
2010-06-30 |
Lg Chem Investment Ltd |
Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same.
|
ES2564144T3
(es)
|
2001-06-29 |
2016-03-18 |
Institute Of Organic Chemistry And Biochemistry Of The Academy Of Sciences Of The Czech Republic |
Derivados de 6-[2-(fosfonometoxi)alcoxi] pirimidina que tienen actividad antivírica
|
IL164809A0
(en)
|
2002-05-13 |
2005-12-18 |
Metabasis Therapeutics Inc |
Novel phosphonic acid basdrugs of pmea and its analogues
|
JP4332496B2
(ja)
|
2002-05-13 |
2009-09-16 |
メタバシス・セラピューティクス・インコーポレイテッド |
Pmeaおよびpmpa環生成合成
|
RU2005108601A
(ru)
*
|
2002-09-26 |
2006-01-20 |
Эл Джи Лайф Сайенсиз Лтд. (Kr) |
(+)-транс-изомеры(1-фосфонометокси-2-алкилциклопропил)метилнуклеозидные производные, способ получения их стереоизомеров и применение указанных соединений в качестве противовирусных средств
|
WO2004035577A2
(en)
*
|
2002-10-16 |
2004-04-29 |
Gilead Sciences, Inc. |
Pre-organized tricyclic integrase inhibitor compounds
|
DE60329211D1
(de)
|
2002-10-31 |
2009-10-22 |
Metabasis Therapeutics Inc |
Cytarabin-monophosphate prodrugs
|
AU2003284800A1
(en)
*
|
2002-11-12 |
2004-06-03 |
Tianjin Kinsly Pharmaceutical Co., Ltd. |
A new crystal form of adefovir dipivoxil and its composition
|
CN105596356A
(zh)
|
2003-01-14 |
2016-05-25 |
吉里德科学公司 |
用于联合抗病毒治疗的组合物和方法
|
US7429565B2
(en)
|
2003-04-25 |
2008-09-30 |
Gilead Sciences, Inc. |
Antiviral phosphonate analogs
|
EA011948B1
(ru)
|
2003-06-16 |
2009-06-30 |
Инститьют Оф Оргэник Кемистри Энд Байокемистри, Экэдеми Оф Сайэнс Оф Зе Чек Рипаблик |
Фосфонатзамещенные пиримидиновые соединения (варианты), способ их получения (варианты), фармацевтическая композиция на их основе и способ лечения вирусной инфекции
|
US20050065171A1
(en)
*
|
2003-06-25 |
2005-03-24 |
Shakespeare William C. |
Substituted purine derivatives
|
JP2007500727A
(ja)
*
|
2003-07-30 |
2007-01-18 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗ウイルス処置のための核酸塩基ホスホネートアナログ
|
AU2004274493A1
(en)
*
|
2003-09-19 |
2005-03-31 |
Gilead Sciences, Inc. |
Aza-quinolinol phosphonate integrase inhibitor compounds
|
EP1689383B1
(en)
*
|
2003-11-19 |
2012-10-31 |
Metabasis Therapeutics, Inc. |
Novel phosphorus-containing thyromimetics
|
PT2204374E
(pt)
*
|
2003-12-30 |
2012-09-17 |
Gilead Sciences Inc |
Fosfonatos nucleosídeos e seus análogos para o tratamento de infecções com hpv
|
KR20060124701A
(ko)
*
|
2004-01-12 |
2006-12-05 |
길리애드 사이언시즈, 인코포레이티드 |
피리미딜 포스포네이트 항바이러스성 화합물 및 그의 사용방법
|
US20080153783A1
(en)
*
|
2004-01-12 |
2008-06-26 |
Gilead Sciences, Inc. |
Pyrimidyl Phosphonate Antiviral Compounds and Methods of Use
|
WO2005090370A1
(en)
|
2004-02-05 |
2005-09-29 |
The Regents Of The University Of California |
Pharmacologically active agents containing esterified phosphonates and methods for use thereof
|
CA2555213C
(en)
*
|
2004-02-17 |
2009-12-01 |
Devron R. Averett |
Nucleoside phosphonate derivatives useful in the treatment of hiv infections
|
PL1742642T3
(pl)
*
|
2004-04-14 |
2009-06-30 |
Gilead Sciences Inc |
Analogi fosfonianowe związków inhibitorów integrazy HIV
|
CN103374041B
(zh)
|
2004-06-08 |
2017-05-10 |
症变治疗公司 |
路易斯酸介导的环状酯的合成
|
CN100338080C
(zh)
*
|
2004-06-16 |
2007-09-19 |
山东中科泰斗化学有限公司 |
9-[2-(膦羧基甲氧基)乙基]腺嘌呤双环醇酯及其制备方法
|
UA93354C2
(ru)
|
2004-07-09 |
2011-02-10 |
Гилиад Сайенсиз, Инк. |
Местный противовирусный препарат
|
EP2316839B1
(en)
*
|
2004-07-16 |
2014-03-12 |
Gilead Sciences, Inc. |
Antiviral heterocyclic compounds having phosphonate groups
|
SI2258376T1
(sl)
*
|
2004-07-27 |
2019-04-30 |
Gilead Sciences, Inc. |
Analogi fosfonata spojin inhibitorjev HIV
|
EP1865967A4
(en)
*
|
2005-04-08 |
2011-02-09 |
Chimerix Inc |
COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS AND OTHER DISEASES
|
JP2008535862A
(ja)
|
2005-04-08 |
2008-09-04 |
キメリクス,インコーポレイテッド |
ポックスウイルス感染の治療のための化合物、組成物および方法
|
AR057023A1
(es)
*
|
2005-05-16 |
2007-11-14 |
Gilead Sciences Inc |
Compuestos heterociclicos con propiedades inhibidoras de hiv-integrasa
|
US20090232879A1
(en)
|
2005-05-26 |
2009-09-17 |
Metabasis Therapeutics, Inc. |
Thyromimetics for the Treatment of Fatty Liver Diseases
|
RU2007148927A
(ru)
*
|
2005-05-26 |
2009-07-10 |
Метабэйзис Терапьютикс, Инк. (Us) |
Новые тиреомиметики, содержащие фосфиновую кислоту
|
TWI375560B
(en)
|
2005-06-13 |
2012-11-01 |
Gilead Sciences Inc |
Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
|
TWI471145B
(zh)
|
2005-06-13 |
2015-02-01 |
Bristol Myers Squibb & Gilead Sciences Llc |
單一式藥學劑量型
|
CN100526315C
(zh)
|
2005-06-16 |
2009-08-12 |
浙江医药股份有限公司新昌制药厂 |
N2-喹啉或异喹啉取代的嘌呤衍生物及其制备方法和其用途
|
TW200738742A
(en)
*
|
2005-07-14 |
2007-10-16 |
Gilead Sciences Inc |
Antiviral compounds
|
TWI389908B
(zh)
*
|
2005-07-14 |
2013-03-21 |
Gilead Sciences Inc |
抗病毒化合物類
|
NZ565059A
(en)
|
2005-07-25 |
2011-08-26 |
Intermune Inc |
Novel macrocyclic inhibitors of hepatitus C virus replication
|
CA2616314A1
(en)
*
|
2005-07-27 |
2007-02-01 |
Gilead Sciences, Inc. |
Antiviral phosphonate conjugates for inhibition of hiv
|
WO2007136714A2
(en)
*
|
2006-05-16 |
2007-11-29 |
Gilead Sciences, Inc. |
Integrase inhibitors
|
WO2008005542A2
(en)
|
2006-07-07 |
2008-01-10 |
Gilead Sciences, Inc., |
Antiviral phosphinate compounds
|
ATE554776T1
(de)
*
|
2006-07-07 |
2012-05-15 |
Gilead Sciences Inc |
Antivirale phosphinatverbindungen
|
CA2657821A1
(en)
*
|
2006-07-21 |
2008-01-24 |
Gilead Sciences, Inc. |
Aza-peptide protease inhibitors
|
CA2657936C
(en)
*
|
2006-07-21 |
2017-01-10 |
Gilead Sciences, Inc. |
Antiviral protease inhibitors
|
FR2908133B1
(fr)
*
|
2006-11-08 |
2012-12-14 |
Centre Nat Rech Scient |
Nouveaux analogues de nucleotides comme molecules precurseurs d'antiviraux
|
CN101190927B
(zh)
*
|
2006-11-30 |
2012-04-18 |
天津天士力集团有限公司 |
9-[2-(膦酰甲氧)乙基]腺嘌呤单特戊酰氧甲酯的制备方法
|
RU2443703C2
(ru)
|
2007-06-18 |
2012-02-27 |
Саншайн Лейк Фарма Ко., Лтд |
Бром-фенил замещенные тиазолилдигидропиримидины
|
ITMI20071594A1
(it)
*
|
2007-08-02 |
2009-02-03 |
Solmag Spa |
Forma cristallina monoidrata di adefovir dipivoxil
|
US8993542B2
(en)
*
|
2008-01-25 |
2015-03-31 |
Chimerix Inc. |
Methods of treating viral infections
|
TWI444384B
(zh)
|
2008-02-20 |
2014-07-11 |
Gilead Sciences Inc |
核苷酸類似物及其在治療惡性腫瘤上的用途
|
WO2009120358A1
(en)
*
|
2008-03-27 |
2009-10-01 |
Nektar Therapeutics |
Oligomer-nitrogenous base conjugates
|
SI2937350T1
(en)
*
|
2008-04-23 |
2018-05-31 |
Gilead Sciences, Inc. |
1'-SUBSTITUTED CARBON-NUCLEOUS ANALOGS FOR ANTIVIRUSAL TREATMENT
|
TW201010692A
(en)
|
2008-06-19 |
2010-03-16 |
Public Univ Corp Nagoya City Univ |
Pharmaceutical composition for treatment or prevention of hbv infection
|
BRPI0915878A2
(pt)
*
|
2008-07-08 |
2015-11-03 |
Gilead Sciences Inc |
sais ou hidratos de compostos inibidores de hiv, seu uso e composição farmacêutica que os compreende
|
KR20100031045A
(ko)
*
|
2008-09-11 |
2010-03-19 |
씨제이제일제당 (주) |
아데포비어 디피복실의 정제방법
|
KR20100032803A
(ko)
*
|
2008-09-18 |
2010-03-26 |
씨제이제일제당 (주) |
아데포비어디피복실의 개선된 제조방법
|
EA201170441A1
(ru)
*
|
2008-10-15 |
2012-05-30 |
Интермьюн, Инк. |
Терапевтические противовирусные пептиды
|
EP2411392B1
(en)
|
2009-03-26 |
2014-02-26 |
Daewoong Pharmaceutical Co., Ltd. |
Novel crystal forms of adefovir dipivoxil and processes for preparing the same
|
TW202042807A
(zh)
|
2009-05-13 |
2020-12-01 |
美商基利法瑪席特有限責任公司 |
抗病毒化合物
|
US8614200B2
(en)
|
2009-07-21 |
2013-12-24 |
Chimerix, Inc. |
Compounds, compositions and methods for treating ocular conditions
|
CN102596979B
(zh)
|
2009-09-21 |
2014-12-10 |
吉里德科学公司 |
用于制备1’-取代碳核苷类似物的方法和中间体
|
LT2480552T
(lt)
|
2009-09-21 |
2017-02-10 |
Gilead Sciences, Inc. |
2'-fluoru pakeisti karbanukleozidų analogai, skirti antivirusiniam gydymui
|
US7973013B2
(en)
|
2009-09-21 |
2011-07-05 |
Gilead Sciences, Inc. |
2'-fluoro substituted carba-nucleoside analogs for antiviral treatment
|
WO2011041551A1
(en)
*
|
2009-10-01 |
2011-04-07 |
Intermune, Inc. |
Therapeutic antiviral peptides
|
EP2343056A1
(en)
|
2009-12-30 |
2011-07-13 |
Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi |
Producing stable adefovir dipivoxil solid dispersions
|
US9006218B2
(en)
|
2010-02-12 |
2015-04-14 |
Chimerix Inc. |
Nucleoside phosphonate salts
|
US20110223131A1
(en)
|
2010-02-24 |
2011-09-15 |
Gilead Sciences, Inc. |
Antiviral compounds
|
EP2563367A4
(en)
|
2010-04-26 |
2013-12-04 |
Chimerix Inc |
METHODS OF TREATING RETROVIRAL INFECTIONS AND ASSOCIATED DOSAGE REGIMES
|
CN101812090B
(zh)
*
|
2010-05-10 |
2013-08-14 |
浙江车头制药股份有限公司 |
一种阿德福韦单酯的制备方法
|
JP2013526581A
(ja)
|
2010-05-21 |
2013-06-24 |
ギリアード サイエンシーズ, インコーポレイテッド |
ヘテロ環式フラビウイルス科ウイルス阻害剤
|
MA34397B1
(fr)
|
2010-07-02 |
2013-07-03 |
Gilead Sciences Inc |
Dérivés d'acide napht-2-ylacétique dans le traitement du sida
|
BR112012033689A2
(pt)
|
2010-07-02 |
2019-09-24 |
Gilead Sciences Inc |
derivados de ácido 2-quinolinil-acético como compostos de hiv antivirais
|
EA025311B1
(ru)
|
2010-07-19 |
2016-12-30 |
Гайлид Сайэнсиз, Инк. |
Способы получения диастереомерно чистых фосфорамидатных пролекарств
|
CN101891767B
(zh)
*
|
2010-07-21 |
2012-05-23 |
浙江贝得药业有限公司 |
一种阿德福韦酯的制备方法
|
SG186830A1
(en)
|
2010-07-22 |
2013-02-28 |
Gilead Sciences Inc |
Methods and compounds for treating paramyxoviridae virus infections
|
WO2012032541A1
(en)
|
2010-09-06 |
2012-03-15 |
Matrix Laboratories Ltd |
"adefovir dipivoxil pseudopolymorph"
|
TW201305185A
(zh)
|
2010-09-13 |
2013-02-01 |
Gilead Sciences Inc |
用於抗病毒治療之2’-氟取代之碳-核苷類似物
|
KR101879887B1
(ko)
|
2010-09-20 |
2018-07-18 |
길리애드 사이언시즈, 인코포레이티드 |
항바이러스 치료용 2'-플루오로 치환된 카바-누클레오시드 유사체
|
CN102093417B
(zh)
*
|
2010-11-15 |
2012-11-28 |
济南久创化学有限责任公司 |
一种可制备核苷膦酸类药物的化合物及其制备方法
|
CA2817840A1
(en)
|
2010-11-17 |
2012-05-24 |
Gilead Sciences, Inc. |
Antiviral compounds
|
CA2818853A1
(en)
|
2010-11-30 |
2012-06-07 |
Gilead Pharmasset Llc |
2'-spirocyclo-nucleosides for use in therapy of hcv or dengue virus
|
CA2819548C
(en)
*
|
2010-12-10 |
2019-04-09 |
Sigmapharm Laboratories, Llc |
Highly stable compositions of orally active nucleotide analogues or orally active nucleotide analogue prodrugs
|
JP6043338B2
(ja)
|
2011-04-13 |
2016-12-14 |
ギリアード サイエンシーズ, インコーポレイテッド |
抗ウイルス治療用の1’−置換ピリミジンn−ヌクレオシド類似体
|
PE20141066A1
(es)
|
2011-04-21 |
2014-09-05 |
Gilead Sciences Inc |
Compuestos de benzotiazol
|
WO2013006738A1
(en)
|
2011-07-06 |
2013-01-10 |
Gilead Sciences, Inc. |
Compounds for the treatment of hiv
|
HUE031253T2
(en)
|
2011-08-16 |
2017-07-28 |
Gilead Sciences Inc |
Tenofovir alafenamid hemifumarate
|
SI2907816T1
(sl)
|
2011-11-16 |
2018-10-30 |
Gilead Pharmasset Llc |
Kondenzirani imidazolilimidazoli kot protivirusni sestavki
|
ES2874774T3
(es)
|
2011-12-22 |
2021-11-05 |
Geron Corp |
Análogos de guanina como sustratos de telomerasa y afectores de la longitud de los telómeros
|
WO2013103738A1
(en)
|
2012-01-04 |
2013-07-11 |
Gilead Sciences, Inc. |
Napthalene acetic acid derivatives against hiv infection
|
US9376392B2
(en)
|
2012-01-04 |
2016-06-28 |
Gilead Sciences, Inc. |
2-(tert-butoxy)-2-(7-methylquinolin-6-yl) acetic acid derivatives for treating AIDS
|
EA201791916A1
(ru)
*
|
2012-03-13 |
2018-07-31 |
Джилид Сайэнс, Инк. |
2'-замещенные карбануклеозидные аналоги для противовирусного лечения
|
PT3070081T
(pt)
|
2012-04-20 |
2018-05-21 |
Gilead Sciences Inc |
Derivados do ácido benzotiazol-6-ilacético e sua utilização para tratar uma infeção por vih
|
JP2015520144A
(ja)
|
2012-05-11 |
2015-07-16 |
アクロン・モレキュールズ・アクチェンゲゼルシャフトAkron Molecules Ag |
疼痛の治療のための化合物の使用
|
US9079887B2
(en)
|
2012-05-16 |
2015-07-14 |
Gilead Sciences, Inc. |
Antiviral compounds
|
US20130309196A1
(en)
|
2012-05-16 |
2013-11-21 |
Gilead Sciences, Inc. |
Antiviral compounds
|
CN107312039B
(zh)
|
2012-08-30 |
2019-06-25 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药的制备方法
|
CN102977146B
(zh)
*
|
2012-11-20 |
2016-04-20 |
广东肇庆星湖生物科技股份有限公司 |
一种腺嘌呤衍生物的合成方法
|
US9233974B2
(en)
|
2012-12-21 |
2016-01-12 |
Gilead Sciences, Inc. |
Antiviral compounds
|
HUE041346T2
(hu)
*
|
2013-03-15 |
2019-05-28 |
Univ California |
Aciklikus nukleozid foszfonát-diészterek
|
CN110156838A
(zh)
*
|
2013-05-14 |
2019-08-23 |
北京美倍他药物研究有限公司 |
磷酸/膦酸衍生物及其医药用途
|
WO2015096697A1
(zh)
*
|
2013-12-23 |
2015-07-02 |
四川海思科制药有限公司 |
非环核苷磷酸酯类衍生物及其制备方法与在医学上的应用
|
AU2015217221A1
(en)
|
2014-02-13 |
2016-08-11 |
Ligand Pharmaceuticals, Inc. |
Prodrug compounds and their uses
|
US10202353B2
(en)
|
2014-02-28 |
2019-02-12 |
Gilead Sciences, Inc. |
Therapeutic compounds
|
WO2015197006A1
(zh)
*
|
2014-06-25 |
2015-12-30 |
四川海思科制药有限公司 |
一种取代的氨基酸硫酯类化合物、其组合物及应用
|
JP2017520545A
(ja)
|
2014-07-02 |
2017-07-27 |
リガンド・ファーマシューティカルズ・インコーポレイテッド |
プロドラッグ化合物およびそれらの使用
|
PL3194411T3
(pl)
|
2014-09-15 |
2022-06-20 |
The Regents Of The University Of California |
Analogi nukleotydów
|
TWI740546B
(zh)
|
2014-10-29 |
2021-09-21 |
美商基利科學股份有限公司 |
製備核糖苷的方法
|
GB201509431D0
(en)
*
|
2015-06-01 |
2015-07-15 |
Equigerminal Sa |
Antiviral composition
|
WO2017048956A1
(en)
|
2015-09-15 |
2017-03-23 |
The Regents Of The University Of California |
Nucleotide analogs
|
PL3785717T3
(pl)
|
2015-09-16 |
2022-05-02 |
Gilead Sciences, Inc. |
Sposoby leczenia infekcji coronaviridae
|
CN105294762A
(zh)
*
|
2015-11-13 |
2016-02-03 |
中国药科大学 |
阿德福韦酯杂质的制备方法
|
CN106800573B
(zh)
*
|
2015-11-25 |
2020-03-10 |
四川海思科制药有限公司 |
一种核苷酸膦酸酯一水合物及其制备方法和在医药上的应用
|
CR20190084A
(es)
|
2016-08-19 |
2019-05-02 |
Gilead Sciences Inc |
Compuestos terapéuticos útiles para el tratamiento profiláctico o terapéutico de una infección por el virus del vih
|
US10449208B2
(en)
*
|
2016-08-25 |
2019-10-22 |
Merck Sharp & Dohme Corp. |
Antiviral prodrugs of tenofovir
|
EP3519409A1
(en)
|
2016-09-28 |
2019-08-07 |
Gilead Sciences, Inc. |
Benzothiazol-6-yl acetic acid derivatives and their use for treating hiv infection
|
CN110198719A
(zh)
|
2016-11-21 |
2019-09-03 |
维京治疗公司 |
治疗糖原贮积病的方法
|
EP3372227A1
(en)
|
2017-03-06 |
2018-09-12 |
MH10 Spolka z ograniczona odpowiedzialnoscia |
Tablet formulation of adefovir dipivoxil
|
CN110869028B
(zh)
|
2017-03-14 |
2023-01-20 |
吉利德科学公司 |
治疗猫冠状病毒感染的方法
|
JP2020518578A
(ja)
|
2017-05-01 |
2020-06-25 |
ギリアード サイエンシーズ, インコーポレイテッド |
(S)−2−エチルブチル2−(((S)−(((2R,3S,4R,5R)−5−(4−アミノピロロ[2,1−f][1,2,4]トリアジン−7−イル)−5−シアノ−3,4−ジヒドロキシテトラヒドロフラン−2−イル)メトキシ)(フェノキシ)ホスホリル)アミノ)プロパノエートの結晶形態
|
CA3064940A1
(en)
|
2017-06-05 |
2018-12-13 |
Viking Therapeutics, Inc. |
Compositions for the treatment of fibrosis
|
TW201919648A
(zh)
|
2017-07-11 |
2019-06-01 |
美商基利科學股份有限公司 |
用於治療病毒感染之含rna聚合酶抑制劑與環糊精的組合物
|
EP3661937B1
(en)
|
2017-08-01 |
2021-07-28 |
Gilead Sciences, Inc. |
Crystalline forms of ethyl ((s)-((((2r,5r)-5-(6-amino-9h-purin-9-yl)-4-fluoro-2,5-dihydrofuran-2-yl)oxy)methyl)(phenoxy)phosphoryl)-l-alaninate (gs-9131) for treating viral infections
|
AR112413A1
(es)
|
2017-08-17 |
2019-10-23 |
Gilead Sciences Inc |
Formas sólidas de un inhibidor de la cápside del vih
|
AR112412A1
(es)
|
2017-08-17 |
2019-10-23 |
Gilead Sciences Inc |
Formas de sal de colina de un inhibidor de la cápside del vih
|
US11970482B2
(en)
|
2018-01-09 |
2024-04-30 |
Ligand Pharmaceuticals Inc. |
Acetal compounds and therapeutic uses thereof
|
CN111836805B
(zh)
|
2018-02-15 |
2023-07-14 |
吉利德科学公司 |
吡啶衍生物及其用于治疗hiv感染的用途
|
CA3175557A1
(en)
|
2018-02-16 |
2019-08-22 |
Gilead Sciences, Inc. |
Methods and intermediates for preparing a therapeutic compound useful in the treatment of retroviridae viral infection
|
US11787828B2
(en)
|
2018-03-22 |
2023-10-17 |
Viking Therapeutics, Inc. |
Crystalline forms and methods of producing crystalline forms of a compound
|
CA3103522C
(en)
|
2018-07-16 |
2023-11-21 |
Gilead Sciences, Inc. |
Capsid inhibitors for the treatment of hiv
|
WO2021074443A1
(en)
|
2019-10-17 |
2021-04-22 |
Ai-Biopharma |
Anti-viral and hepatic-targeted drugs
|
CN114727999A
(zh)
|
2019-11-26 |
2022-07-08 |
吉利德科学公司 |
用于预防hiv的衣壳抑制剂
|
US11660307B2
(en)
|
2020-01-27 |
2023-05-30 |
Gilead Sciences, Inc. |
Methods for treating SARS CoV-2 infections
|
TWI785528B
(zh)
|
2020-03-12 |
2022-12-01 |
美商基利科學股份有限公司 |
1’-氰基核苷之製備方法
|
EP4132651A1
(en)
|
2020-04-06 |
2023-02-15 |
Gilead Sciences, Inc. |
Inhalation formulations of 1'-cyano substituted carbanucleoside analogs
|
CA3179226A1
(en)
|
2020-05-29 |
2021-12-02 |
Tomas Cihlar |
Remdesivir treatment methods
|
PE20230618A1
(es)
|
2020-06-24 |
2023-04-14 |
Gilead Sciences Inc |
Analogos de nucleosido de 1'-ciano y usos de los mismos
|
CA3181690A1
(en)
|
2020-06-25 |
2021-12-30 |
Chienhung CHOU |
Capsid inhibitors for the treatment of hiv
|
TW202233204A
(zh)
|
2020-08-27 |
2022-09-01 |
美商基利科學股份有限公司 |
用於治療病毒感染之化合物及方法
|
CA3220903A1
(en)
|
2021-05-21 |
2022-11-24 |
Gilead Sciences, Inc. |
Pentacyclic derivatives as zika virus inhibitors
|
CN113880883A
(zh)
*
|
2021-11-11 |
2022-01-04 |
奥锐特药业股份有限公司 |
核苷类磷酸酯前药的制备方法
|
US11787825B2
(en)
|
2021-12-03 |
2023-10-17 |
Gilead Sciences, Inc. |
Therapeutic compounds for HIV virus infection
|
US20230295172A1
(en)
|
2022-03-02 |
2023-09-21 |
Gilead Sciences, Inc. |
Compounds and methods for treatment of viral infections
|